Asker Healthcare Group AB (publ) (STO:ASKER)
78.40
+1.85 (2.42%)
Jul 28, 2026, 5:29 PM CET
Asker Healthcare Group AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 777 | 884 | 490 | 391 | 211 | 494 |
Cash & Short-Term Investments | 777 | 884 | 490 | 391 | 211 | 494 |
Cash Growth | -41.36% | 80.41% | 25.32% | 85.31% | -57.29% | - |
Accounts Receivable | 2,096 | 2,052 | 1,725 | 1,744 | 1,394 | 1,106 |
Other Receivables | 557 | 148 | 137 | 79 | 232 | 118 |
Total Trade Receivables | 2,653 | 2,200 | 1,862 | 1,823 | 1,626 | 1,224 |
Inventory | 2,364 | 2,041 | 1,821 | 1,439 | 1,420 | 1,116 |
Other Current Assets | - | 346 | 310 | 343 | 151 | 120 |
Total Current Assets | 5,794 | 5,472 | 4,483 | 3,996 | 3,408 | 2,954 |
Net Property, Plant & Equipment | 1,877 | 1,780 | 1,490 | 1,003 | 903 | 607 |
Other Intangible Assets | 3,274 | 3,027 | 1,954 | 1,587 | 1,424 | 386 |
Goodwill | 6,758 | 6,369 | 5,100 | 4,701 | 4,469 | 3,362 |
Long-Term Investments | - | 0 | 2 | 2 | - | - |
Other Long-Term Assets | 128 | 126 | 89 | 38 | 30 | 52 |
Total Assets | 17,832 | 16,774 | 13,118 | 11,326 | 10,234 | 7,361 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,672 | 1,610 | 1,344 | 1,433 | 1,047 | 866 |
Accrued Expenses | - | 623 | 493 | 437 | 399 | 289 |
Current Portion of Long-Term Debt | 1,148 | 557 | 374 | 251 | 115 | 141 |
Current Portion of Leases | 344 | 306 | 237 | 170 | 149 | 106 |
Other Current Liabilities | 1,274 | 942 | 749 | 574 | 522 | 278 |
Total Current Liabilities | 4,439 | 4,037 | 3,198 | 2,864 | 2,233 | 1,680 |
Long-Term Debt | 4,256 | 4,224 | 4,628 | 3,987 | 3,992 | 3,038 |
Long-Term Leases | 728 | 727 | 719 | 565 | 485 | 344 |
Other Long-Term Liabilities | 1,390 | 1,198 | 1,071 | 868 | 733 | 479 |
Total Long-Term Liabilities | 6,374 | 6,149 | 6,419 | 5,420 | 5,210 | 3,861 |
Total Liabilities | 10,813 | 10,186 | 9,617 | 8,284 | 7,443 | 5,541 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 1 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | - | 4,435 | 1,571 | 1,571 | 1,508 | 1,109 |
Accumulated Other Comprehensive Income | - | -26 | 245 | 148 | 137 | -6 |
Retained Earnings | - | 2,145 | 1,652 | 1,304 | 1,118 | 688 |
Total Common Shareholders' Equity | 6,978 | 6,555 | 3,469 | 3,023 | 2,763 | 1,791 |
Minority Interest | 41 | 33 | 33 | 18 | 28 | 29 |
Shareholders' Equity | 7,018 | 6,588 | 3,502 | 3,042 | 2,791 | 1,820 |
Total Liabilities & Equity | 17,832 | 16,774 | 13,118 | 11,326 | 10,234 | 7,361 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6,476 | 5,814 | 5,958 | 4,973 | 4,741 | 3,629 |
Net Cash (Debt) | -5,699 | -4,930 | -5,468 | -4,582 | -4,530 | -3,135 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -14.88 | -13.39 | -17.02 | -17.48 | -17.55 | -13.30 |
Book Value | 6,978 | 6,555 | 3,469 | 3,023 | 2,763 | 1,791 |
Book Value Per Share | 18.22 | 17.80 | 10.79 | 11.53 | 10.70 | 7.60 |
Tangible Book Value | -3,054 | -2,841 | -3,585 | -3,265 | -3,130 | -1,957 |
Tangible Book Value Per Share | -7.97 | -7.71 | -11.16 | -12.45 | -12.12 | -8.30 |